In a study published in Advanced Materials on July 22, a team led by Dr. ZHONG Chao and Dr. AN Bolin from the Shenzhen ...

Ischemic retinopathy refers to a group of ocular disorders characterized by insufficient retinal blood flow, leading to hypoxia and subsequent retinal tissue damage. In the hypoxic environment, ...

North America leads with over 34% market share, while APAC shows a robust growth of 9.03%. Major players like Alcon, Carl ...

Samsung Bioepis Co., Ltd. ("Samsung Bioepis") announced today that the company has entered into a license, development and commercialization agreement (DCA) with Harrow (Nasdaq: HROW), for Samsung ...

Annexon has completed enrollment in its phase 3 ARCHER II trial of vonaprument (formerly ANX007) for dry age-related macular ...

To mark Ophthalmology Times' 50th anniversary, we invited top experts to reflect on the most significant innovations in ...

Harrow has entered into an agreement with Samsung Bioepis for the U.S. commercial rights to two ophthalmology biosimilars, according to a press release.The agreement includes Byooviz (ranibizumab-nuna ...

A new study published in the journal of Eye showed that in some ethnic groups like the non-Hispanic Whites and ...

The commercial license will become effective upon completion of the transition of commercial rights from Biogen back to ...

Global regulatory advancements in biosimilars enhance access to affordable treatments for autoimmune disorders, bone diseases ...

Age-related macular degeneration (AMD) is still referred to as the leading cause of severe and irreversible visual loss world-wide. The disease has a profound effect on quality of life of affected ...